This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991:57:153-195.

doi: 10.1007/978-3-7091-9119-4_3.

The bryostatins

G R Pettit¹

Affiliations

PMID: 1937312
DOI: 10.1007/978-3-7091-9119-4_3

Review

The bryostatins

G R Pettit. Fortschr Chem Org Naturst. 1991.

. 1991:57:153-195.

doi: 10.1007/978-3-7091-9119-4_3.

Author

G R Pettit¹

Affiliation

¹ Cancer Research Institute, Arizona State University, Tempe.

PMID: 1937312
DOI: 10.1007/978-3-7091-9119-4_3

No abstract available

PubMed Disclaimer

Similar articles

Chemistry and clinical biology of the bryostatins.
Mutter R, Wills M. Mutter R, et al. Bioorg Med Chem. 2000 Aug;8(8):1841-60. doi: 10.1016/s0968-0896(00)00150-4. Bioorg Med Chem. 2000. PMID: 11003129 Review.
Antineoplastic agents. 340. Isolation and structural elucidation of bryostatins 16-18.
Pettit GR, Gao F, Blumberg PM, Herald CL, Coll JC, Kamano Y, Lewin NE, Schmidt JM, Chapuis JC. Pettit GR, et al. J Nat Prod. 1996 Mar;59(3):286-9. doi: 10.1021/np960100b. J Nat Prod. 1996. PMID: 8882431
The clinical development of the bryostatins.
Clamp A, Jayson GC. Clamp A, et al. Anticancer Drugs. 2002 Aug;13(7):673-83. doi: 10.1097/00001813-200208000-00001. Anticancer Drugs. 2002. PMID: 12187323 Review.
Asymmetric synthesis of the northern half C1-C16 of the bryostatins.
Vakalopoulos A, Lampe TF, Hoffmann HM. Vakalopoulos A, et al. Org Lett. 2001 Mar 22;3(6):929-32. doi: 10.1021/ol015551o. Org Lett. 2001. PMID: 11263918
Bryostatin 1: differentiating agent from the depths.
Stone RM. Stone RM. Leuk Res. 1997 May;21(5):399-401. doi: 10.1016/s0145-2126(96)00123-3. Leuk Res. 1997. PMID: 9225066 Review. No abstract available.

See all similar articles

Cited by

Neristatin 1 provides critical insight into bryostatin 1 structure-function relationships.
Kedei N, Kraft MB, Keck GE, Herald CL, Melody N, Pettit GR, Blumberg PM. Kedei N, et al. J Nat Prod. 2015 Apr 24;78(4):896-900. doi: 10.1021/acs.jnatprod.5b00094. Epub 2015 Mar 26. J Nat Prod. 2015. PMID: 25808573 Free PMC article.
Evidence for the biosynthesis of bryostatins by the bacterial symbiont "Candidatus Endobugula sertula" of the bryozoan Bugula neritina.
Davidson SK, Allen SW, Lim GE, Anderson CM, Haygood MG. Davidson SK, et al. Appl Environ Microbiol. 2001 Oct;67(10):4531-7. doi: 10.1128/AEM.67.10.4531-4537.2001. Appl Environ Microbiol. 2001. PMID: 11571152 Free PMC article.
Marine natural products with P-glycoprotein inhibitor properties.
Lopez D, Martinez-Luis S. Lopez D, et al. Mar Drugs. 2014 Jan 22;12(1):525-46. doi: 10.3390/md12010525. Mar Drugs. 2014. PMID: 24451193 Free PMC article. Review.
"Candidatus Endobugula glebosa," a specific bacterial symbiont of the marine bryozoan Bugula simplex.
Lim GE, Haygood MG. Lim GE, et al. Appl Environ Microbiol. 2004 Aug;70(8):4921-9. doi: 10.1128/AEM.70.8.4921-4929.2004. Appl Environ Microbiol. 2004. PMID: 15294832 Free PMC article.
Current status on marine products with reversal effect on cancer multidrug resistance.
Abraham I, El Sayed K, Chen ZS, Guo H. Abraham I, et al. Mar Drugs. 2012 Oct;10(10):2312-2321. doi: 10.3390/md10102312. Epub 2012 Oct 19. Mar Drugs. 2012. PMID: 23170086 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database